A Phase I/IIb Study of Personalized Neoantigen Peptide-Based Cancer Vaccine for Patients with Solid Tumors
Latest Information Update: 07 Oct 2024
At a glance
- Drugs SQK 01 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Seqker Biosciences
- 07 Oct 2024 New trial record